Table 4.
Secondary outcomes by intervention type
| Author | References | Approach | Follow-Up (months) | Mortality | Infection | HHS | PMA | ||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | Outcome | Baseline | Outcome | ||||||
| Anterolateral | |||||||||
| Chughtai et al. | [41] | ALA | 36 | – | 2 (0.5) | 51 | 94 ± 6 | – | – |
| Fessy et al.† | [50] | ALA | 104.4 | – | – | – | – | – | – |
| Lamo-Espinosa et al. | [64] | ALA | 49.0 | – | 2 (2.9) | – | – | 10.31 | 15.61 |
| Vielpeau et al. | [87] | ALA | 151.1 | 182 (37.1) | – | – | – | – | – |
| Direct Anterior | |||||||||
| Baker et al. | [32] | DAA | 81.2 | 6 (4.2) | 2 (1.3) | – | – | – | – |
| Batailler et al.† | [33] | DAA | 14 | 2 (1.1) | 0 (0.0) | 50.2 ± 14 | 95.9 | – | 17.3 |
| Homma et al. | [61] | DAA | 15.7 | 1 (1.2) | 1 (1.2) | – | – | – | – |
| Randelli et al. | [80] | DAA | 23.6 | 0 (0.0) | 0 (0.0) | – | – | – | – |
| Singh et al. † | [84] | DAA | ≥ 12 | – | – | – | – | – | – |
| Direct Lateral | |||||||||
| Henawy and Badie | [59] | DLA | ≥ 12 | 0 (0.0) | 1 (4.2) | 36 | 94 | 8 | 17 |
| Posterior | |||||||||
| Acker et al. | [29] | PLA | 67.2 | – | – | – | – | – | – |
| Almeida | [30] | PLA | 24–74 | – | – | – | – | – | – |
| Asselineau et al. | [31] | PLA | 57 | – | – | – | – | – | – |
| Assi et al. | [2] | PLA | 59.9 | – | 1 (1.3) | – | – | – | – |
| Batailler et al.† | [33] | PLA | 14 | 1 (1.1) | 0 (0.0) | – | 89.6 | – | 16.5 |
| Bauchu et al. | [34] | PLA | 74.4 | 20 (13.3) | 1 (0.7) | – | – | 8.9 ± 2.3 | 17.1 ± 1.2 |
| Beckert et al. | [35] | PLA | 49 | – | – | – | – | – | – |
| Belgaïd et al. | [36] | PLA | 96 | 48 (40.0) | 2 (1.6) | 47.9 ± 12.8 | 83 ± 14 | – | – |
| Bouchet et al. | [37]1 | PLA | 28 | – | – | – | – | – | – |
| Chalmers et al. | [38] | PLA | 24 | 0 (0.0) | – | – | – | – | – |
| Chalmers et al. | [39] | PLA | 36 | 0 (0.0) | 2 (2.3) | – | – | – | – |
| Dagneaux et al. | [42] | PLA | 6 | – | – | – | – | – | – |
| Dubin et al. | [44] | PLA | 68.4 | – | – | – | 78.95 ± 18.65 | – | – |
| Dubin et al. | [45] | PLA | 25.4 | 8 (1.2) | – | 54.03 ± 12.94 | 91.44 ± 12.76 | – | – |
| Dubin et al. | [46] | PLA | 34.8 | – | – | – | – | – | – |
| Epinette et al. | [47] | PLA | 48 | 20 (4.8) | 1 (0.2) | 36.16 | 93.38 | – | 16.71 |
| Epinette et al. | [48] | PLA | 79.2 | 1 (3.2) | 0 (0.0) | – | – | – | – |
| Fessy et al.† | [50] | PLA | 104.4 | – | – | – | – | – | – |
| Fiquet and Noyer | [51] | PLA | < 36 | – | – | – | – | – | – |
| Fresard et al. | [53] | PLA | 64.8 | 24 (17.9) | 1 (0.7) | 51.3 ± 14 | 88 ± 12 | 8 ± 3 | 16.3 ± 2.9 |
| Gaillard et al. | [54] | PLA | 152.4 | – | 0 (0.0) | 45.7 | 94.9 | 11.7 | 17.6 |
| Gkiatas et al. | [55] | PLA | 93.6 | – | 2 (1.0) | – | – | – | – |
| Haen et al. | [56] | PLA | 50.4 | – | – | – | – | – | – |
| Hamadouche et al. | [57] | PLA | 72 | – | – | – | – | – | – |
| Haughom et al. | [58] | PLA | ≥ 1.5 | – | – | – | – | – | – |
| Hernigou et al. | [60] | PLA | 216 | 35 (8.1) | – | – | –– | – | – |
| Jorgensen et al. | [62] | PLA | 72 | 9 (15.3) | 1 (1.7) | 56.5 | 89.5 | – | – |
| Kumar et al. | [63] | PLA | 12* | – | – | 68.0 ± 5.3 | 83.0 ± 3.7 | – | – |
| Laurendon et al. | [65] | PLA | 120 | 19 (20.4) | – | 56 ± 15.2 | 93 ± 8.4 | 11.8 ± 2.1 | 17 ± 1.6 |
| Londhe et al. | [66] | PLA | 67.5 | ||||||
| Luthra et al. | [67] | PLA | 60 | – | – | – | – | – | – |
| Maisongrosse et al. ‡ | [68] | PLA | 54.0 | – | – | – | – | – | – |
| Massin et al. | [70] | PLA | 92.4 | 436 (18.1) | 24 (0.9) | – | – | – | – |
| Moon et al. | [71] | PLA | 37.2 | 0 (0.0) | 0 (0.0) | – | 90.5 ± 9.8 | – | – |
| Nam et al. | [72] | PLA | 24 | – | – | 54.1 ± 20.5 | 91.2 ± 10.8 | – | – |
| Neri et al. | [73] | PLA | 303.6 | 76 (43.7) | 2 (0.9) | 51.1 | 83.6 | 11.2 | 16.9 |
| Paderni et al. | [75] | PLA | 27 | – | – | – | – | – | – |
| Pattyn et al. | [76] | PLA | 43.2 | 17 (16.3) | 1 (1.0) | – | 93 | – | – |
| Philippot et al. | [77] | PLA | 120 | 12 (13.3) | 2 (1.9) | – | – | 7.1 ± 0.4 | 15.8 ± 0.8 |
| Prudhon et al. | [78] | PLA | 163.3 | 92 (21.6) | 2 (0.4) | – | – | – | – |
| Rowan et al. | [81] | PLA | 40 | – | – | 47.7 ± 14.4 | 87.2 ± 16.6 | – | – |
| Sanders et al. | [82] | PLA | 38.2 | 0 (0.0) | 0 (0.0) | – | – | – | – |
| Schneider et al. | [83] | PLA | 34.1 | – | – | – | – | – | – |
| Singh et al. † | [84] | PLA | ≥ 12 | – | – | – | – | – | – |
| Vermersch et al. | [86] | PLA | 72 | 12 (12.0) | 1 (1.0) | 56 | 94 | 13 | 17 |
| Vigdorchik et al. | [88] | PLA | 36 | 4 (0.9) | 0 (0.0) | 41 | 86 | – | – |
| Viricel et al. | [89] | PLA | 117.6 | 5 (6.3) | 5 (5.5) | 57.9 ± 13.7 | 95 ± 15.33 | 11.09 ± 2.59 | 17.33 ± 1.07 |
| Yang et al. | [90] | PLA | 61.2 | 2 (1.3) | – | 42.6 | 82.2 | – | – |
| Combined | |||||||||
| Boyer et al. | [10] |
PLA DLA |
264* | – | – | – | – | – | – |
| Chouteau et al. | [40] |
PLA ALA |
100.8 | 50 (22.5) | 4 (1.7) | 41.7 ± 13.1 | 83.6 ± 13.2 | – | – |
| Dhawan et al. | [43] |
PLA DAA |
14 | 1 (0.4) | 1 (0.4) | – | – | – | – |
| Ferreira et al. | [49] |
PLA DLA |
≥ 36 | – | – | – | – | – | |
| Foissey et al. | [52] |
DAA PLA |
70 | – | 2 (1.2) | 48.3 ± 6.0 | 83.6 ± 13.2 | – | – |
| Martz et al. | [69] |
PLA DLA |
116.8 | 11 (35.5) | 1 (2.5) | 50.8 ± 15.5 | 95.7 ± 6.9 | 11 ± 3.3 | 17.4 ± 1.12 |
| Nessler et al. | [74] |
PLA DLA DAA |
32.2 | – | 0 (0.0) | – | – | – | – |
| Puch et al. ‡ | [79] |
PLA DLA |
132 | 4 (3.3) | 1 (0.8) | 39.5 | 98.0 | 8.8 | 17.0 |
Data are reported as n(%), mean, or mean ± standard deviation, unless indicated otherwise
*Median is reported instead of mean
†Multi-armed study including patients who received both anterior-based and posterior-based approaches
‡Single extractable cohort from a study
– Not available, ALA—Anterolateral approach, DAA—Direct anterior approach, DLA—Direct lateral approach, PLA—Posterolateral approach, PMA—Postel-Merle d’Aubigné, HHS—Harris Hip Score